Apimostinel

DB11784InvestigationalSmall molecule

NRX-1074 has been used in trials studying the treatment of Schizophrenia.

Chemical structure of Apimostinel
Mechanism
Curator reviewed
Formula / weight
C25H37N5O6 · 503.6 g/mol (avg)
Code names
NRX-1074

Resolves to

Compound
UNIITTT1F11FZBCAS1421866-48-9ChEMBLCHEMBL3989872PubChem71249967
Structure
InChIKeyDVBUEXCIEIAXPM-PJUQSVSOSA-NSMILESC[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@@]1(CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(N)=O

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Apimostinel, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In